FAM19A5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.11022302462516E-16 |
Normal-vs-Stage2 |
5.592100E-04 |
Normal-vs-Stage3 |
1.57640012155014E-10 |
Normal-vs-Stage4 |
6.08189999999897E-05 |
Stage1-vs-Stage2 |
7.494200E-01 |
Stage1-vs-Stage3 |
1.454280E-02 |
Stage1-vs-Stage4 |
2.604400E-01 |
Stage2-vs-Stage3 |
3.432600E-01 |
Stage2-vs-Stage4 |
6.116800E-01 |
Stage3-vs-Stage4 |
6.142200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
5.68789999999542E-05 |
Normal-vs-Asian |
7.522100E-02 |
Caucasian-vs-AfricanAmerican |
1.389840E-01 |
Caucasian-vs-Asian |
7.862800E-01 |
AfricanAmerican-vs-Asian |
1.930980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
5.09581266072701E-12 |
Male-vs-Female |
7.954300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.631200E-04 |
Normal-vs-Age(41-60Yrs) |
1.62891922173003E-12 |
Normal-vs-Age(61-80Yrs) |
3.44169137633799E-15 |
Normal-vs-Age(81-100Yrs) |
1.808220E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.380950E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.236570E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.563200E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.401400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.553540E-04 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.967800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.216210E-03 |
Normal-vs-Grade 2 |
1.6242562850266E-12 |
Normal-vs-Grade 3 |
3.56909946042094E-10 |
Normal-vs-Grade 4 |
1.69008999999498E-05 |
Grade 1-vs-Grade 2 |
8.342600E-01 |
Grade 1-vs-Grade 3 |
1.998620E-01 |
Grade 1-vs-Grade 4 |
3.003600E-02 |
Grade 2-vs-Grade 3 |
7.022600E-03 |
Grade 2-vs-Grade 4 |
7.361900E-04 |
Grade 3-vs-Grade 4 |
3.593400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.68114436102951E-12 |
Normal-vs-ccB subtype |
2.44249065417534E-15 |
ccA subtype-vs-ccB subtype |
7.948600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.65500946280872E-12 |
Normal-vs-N1 |
2.165600E-02 |
N0-vs-N1 |
6.773400E-01 |
|
|